Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Nanoparticle Vaccines Based on the Receptor Binding Domai... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
0
Authors
Xiancai Ma
24 more
Xiancai Ma
•
Fei Yu
22 more
•
Hui Zhang
Published
November 25, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Immunity
Topics
Biology
Biochemistry
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/j.immuni.2020.11.015
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Immunity
Topics
Biology
Biochemistry
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/j.immuni.2020.11.015
License
publisher-specific-oa
